J&J Wins Dismissal of Talc Class Suit for Medical Monitoring (1)

Johnson & Johnson can avoid a proposed class action to cover medical screening costs incurred by individuals worried about developing ovarian or gynecological cancers from using J&J talc products, a New Jersey federal judge ruled, finding no concrete injury was alleged.

Lacking a cancer diagnosis, lead plaintiff Joni Bynum hasn’t plausibly alleged an economic injury caused by J&J or provided enough basis to support a medical monitoring claim under New Jersey or Washington state law, Judge Michael A. Shipp of the US District Court for the District of New Jersey ruled Thursday.

The complaint also suffers from defects that prevent ...